State of Alaska Department of Revenue’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-111,058
| Closed | -$5.83M | – | 1690 |
|
|
2020
Q3 | $5.83M | Buy |
111,058
+20
| +0% | +$828 | 0.07% | 311 |
|
|
2020
Q2 | $3.69M | Buy |
111,038
+10,840
| +11% | +$345K | 0.05% | 435 |
|
|
2020
Q1 | $2.73M | Buy |
100,198
+14,469
| +17% | +$403K | 0.04% | 429 |
|
|
2019
Q4 | $1.69M | Buy |
85,729
+9,902
| +13% | +$158K | 0.02% | 648 |
|
|
2019
Q3 | $982K | Buy |
75,827
+42,300
| +126% | +$511K | 0.01% | 859 |
|
|
2019
Q2 | $417K | Buy |
33,527
+326
| +1% | +$4.33K | 0.01% | 1158 |
|
|
2019
Q1 | $482K | Buy |
33,201
+1,100
| +3% | +$14.1K | 0.01% | 1083 |
|
|
2018
Q4 | $354K | Buy |
32,101
+6,547
| +26% | +$91.1K | 0.01% | 1160 |
|
|
2018
Q3 | $672K | Buy |
25,554
+180
| +0.7% | +$4.87K | 0.01% | 932 |
|
|
2018
Q2 | $518K | Buy |
25,374
+570
| +2% | +$12.2K | 0.01% | 1049 |
|
|
2018
Q1 | $450K | Buy |
24,804
+9,620
| +63% | +$160K | 0.01% | 1017 |
|
|
2017
Q4 | $211K | Buy |
15,184
+130
| +0.9% | +$1.76K | 0.01% | 1244 |
|
|
2017
Q3 | $278K | Buy |
15,054
+1,870
| +14% | +$31.3K | 0.01% | 884 |
|
|
2017
Q2 | $222K | Buy |
13,184
+6,044
| +85% | +$92K | 0.02% | 818 |
|
|
2017
Q1 | $95K | Buy |
7,140
+200
| +3% | +$3.13K | 0.01% | 971 |
|
|
2016
Q4 | $104K | Buy |
+6,940
| New | +$91.7K | 0.01% | 654 |
|
State of Alaska Department of Revenue's MNTA Position: Q4 2020 in Review
State of Alaska Department of Revenue sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 111,058 shares — an estimated $5.83M sold.
State of Alaska Department of Revenue first reported a position in MNTA in Q4 2016 and held it in 16 quarters. The position peaked at $5.83M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- State of Alaska Department of Revenue reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- State of Alaska Department of Revenue sold 111,058 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $5.83M.
- State of Alaska Department of Revenue first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2016 and held it in 16 quarters.
- State of Alaska Department of Revenue's Momenta Pharmaceuticals, Inc. position peaked at $5.83M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on State of Alaska Department of Revenue's 13F filing for Q4 2020, filed 8 Jan 2021.